Search - tctmd.com

Displaying 61 - 80 of 82

Sort: Relevancy | Date

Presentation EuroPCR 2016

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

Presenter: Robert-Jan van Geuns

May 18, 2016

News Conference News EuroPCR 2016

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Michael O'Riordan

May 17, 2016

News Conference News EuroPCR 2015

Preconditioning, Postconditioning Join Forces to Limit STEMI Damage

Caitlin E. Cox

May 22, 2015

News Conference News EuroPCR 2015

MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI

Caitlin E. Cox

May 20, 2015

News Conference News EuroPCR 2015

PRAGUE-13 Finds No Advantage to Complete Revascularization After Primary PCI

Caitlin E. Cox

May 19, 2015

Presentation EuroPCR 2015

Multivessel Coronary Disease Diagnosed at the Time of Primary PCI for STEMI: Complete Revascularization Versus Conservative Strategy - PRAGUE 13 Trial

Presenter: Ota Hlinomaz

May 19, 2015

News Conference News EuroPCR 2015

DEFER at 15 Years: Postponing PCI Based on FFR in Stable Angina Lowers MI Risk

Yael L. Maxwell

May 19, 2015

$Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial$

Presentation EuroPCR 2014

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Presenter: Uwe Zeymer

May 21, 2014

News Conference News EuroPCR 2014

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

Yael L. Maxwell

May 21, 2014

News Conference News EuroPCR 2013

ELISA-3: Early vs. Late Intervention No Different for High-Risk NSTE ACS Patients

Caitlin E. Cox

May 24, 2013

News Conference News EuroPCR 2013

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Yael L. Maxwell

May 23, 2013

News Conference News EuroPCR 2013

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

Caitlin E. Cox

May 23, 2013

News Conference News EuroPCR 2013

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

Caitlin E. Cox

May 22, 2013

Presentation EuroPCR 2012

APPOSITION III: Evaluation of the STENTYS self-apposing bare and drug-eluting stent in 1000 STEMI patients in a real-life setting: in-hospital and 30-day outcomes

Presenter: 166648|giovanni amoroso

May 18, 2012

News Conference News EuroPCR 2012

Thrombectomy Results Underwhelming in AMI Patients

Jason Kahn

May 17, 2012

Presentation EuroPCR 2012

CompariSon of Manual Aspiration with Rheolytic Thrombectomy in Acute Myocardial Infarction: the SMART Primary PCI Trial

Presenter: David Antoniucci

May 16, 2012

News Conference News EuroPCR 2012

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Jason Kahn

May 15, 2012

News Conference News

Transradial Primary PCI Lowers Mortality in STEMI Patients

Jason Kahn

May 20, 2011

News Conference News

POST-AMI: Postconditioning Not Helpful, Possibly Harmful in STEMI Patients

Caitlin E. Cox

May 19, 2011

News Conference News

EPO Augments Effect of Novel Stent in STEMI Patients

Caitlin E. Cox

May 19, 2011

Advertisement

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Preconditioning, Postconditioning Join Forces to Limit STEMI Damage

MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI

PRAGUE-13 Finds No Advantage to Complete Revascularization After Primary PCI

Multivessel Coronary Disease Diagnosed at the Time of Primary PCI for STEMI: Complete Revascularization Versus Conservative Strategy - PRAGUE 13 Trial

DEFER at 15 Years: Postponing PCI Based on FFR in Stable Angina Lowers MI Risk

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

ELISA-3: Early vs. Late Intervention No Different for High-Risk NSTE ACS Patients

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

APPOSITION III: Evaluation of the STENTYS self-apposing bare and drug-eluting stent in 1000 STEMI patients in a real-life setting: in-hospital and 30-day outcomes

Thrombectomy Results Underwhelming in AMI Patients

CompariSon of Manual Aspiration with Rheolytic Thrombectomy in Acute Myocardial Infarction: the SMART Primary PCI Trial

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Transradial Primary PCI Lowers Mortality in STEMI Patients

POST-AMI: Postconditioning Not Helpful, Possibly Harmful in STEMI Patients

EPO Augments Effect of Novel Stent in STEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content